NEWS & EVENTS
Dr. Joachim Kohn, AFIRM's Director and an NIBIB Principal Investigator, takes people ravaged by war and helps discover new ways to put them (literally) back together through tissue engineering, renerative processes like bone and nerve repair, face transplants, human transplantation, and an engineered skin substitute for burns. Read the full article from Wired.com.
A new study by University of Kentucky researchers, carried out in the laboratory of Pexiuan Guo, an NIBIB PI, shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. Read the full article from University of Kentucky.
Point-of-care tests for chlamydia as developed by NIBIB-funded researcher Charlotte Gaydos are more cost-effective than traditional nucleic acid amplification test (NAAT) in a clinic when specified characteristics (sensitivity, specificity, cost, and willingness to wait in a clinic for POC test results) are met. Read the full article from Johns Hopkins.